Generic Portfolio
Various
ApprovedCommercial
Key Facts
About Strides Pharma
Strides Pharma is a global pharmaceutical company headquartered in Bengaluru, India, with a core mission to provide affordable, high-quality generic medicines worldwide. The company has established itself as a leader in niche and complex therapeutic segments, including anti-retrovirals, anti-malarials, and softgel technologies, with a significant footprint in the US, Africa, Asia, and other regulated markets. Its strategic direction involves expanding its portfolio of complex generics, biosimilars, and specialty products while leveraging its robust manufacturing and R&D capabilities. Key achievements include a successful IPO, strategic acquisitions, and a consistent track record of ANDA filings and approvals in the US market.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Programs | Richter Gedeon | Phase 3 |
| Oligonucleotide APIs | Bachem | Clinical/Commercial |
| Novel Plasma-derived Therapies | Tiantan Bio | Pre-clinical |
| Complex Injectable Generics Pipeline | Amphastar Pharmaceuticals | ANDA Filed / Development |
| New Product Launches | FDC India | Development/Filing |
| Generic Products Portfolio | Celon Pharma | Approved/Commercial |
| New Generic Filings (e.g., for US/EU) | Bliss GVS Pharma | Regulatory Review |
| Pipeline of Complex Generics | Mayne Pharma Group | Development |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |